MONKEYPOX (MPOX) DIAGNOSIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Monkeypox (Mpox) Diagnosis Market, By Test Type (Polymerase Chain Reaction (PCR) Tests, Serological Tests, Antigen Detection Tests, and Viral Culture Tests), By Mode (Laboratory Testing and Point of Care Testing), By Component (Hardware and Software), By End User (Hospitals and Clinics, Diagnostic Laboratories, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Nov 2024
Code : CMI7495
Pages :145
Formats :
Excel and PDF
Industry : Pharmaceutical

Key Takeaways from Analyst

The recent monkeypox outbreak has boosted the demand for reliable diagnostics, with North America leading due to high case numbers. polymerase chain reaction tests, the primary diagnostic method, are offered by companies like Roche, Abbott, and BioMerieux, but require specialized labs and processing time, creating a need for faster solutions. Point-of-care antigen tests are gaining interest but face regulatory and funding challenges. Additionally, symptom overlap with conditions like chickenpox and undetected rashes complicates accurate diagnosis, highlighting the potential for combined DNA and antibody detection.

MONKEYPOX (MPOX) DIAGNOSIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Monkeypox (Mpox) Diagnosis Market Report Snapshots

EXISTING CLIENTELE